Your Apple Watch Says You Might Have AFib. Now What? | Philadelphia

TL;DR30-second take

If your Apple Watch, Fitbit, Samsung, Oura, or Withings device flags an irregular rhythm or possible atrial fibrillation, treat it as a screening alert worth acting on rather than a diagnosis. These devices read your pulse with an optical sensor, and some add a single-lead ECG you trigger yourself, but neither is enough to diagnose AFib on its own. The next step is a medical-grade test, a 12-lead ECG in the office or a wearable patch monitor worn for one to two weeks, to confirm whether AFib is present. AFib matters because it roughly triples to quintuples stroke risk, so it is worth taking seriously. But the decision about blood thinners or any treatment rests on a stroke-risk score and a physician, never on a watch. And AFib is often improvable: weight loss, cutting alcohol, treating sleep apnea, and controlling blood pressure can reduce how often it happens.

TL;DR: A smartwatch alert for an irregular rhythm or possible atrial fibrillation is a reason to act, but it is a screening flag rather than a diagnosis. Wrist wearables read your pulse with an optical sensor, and some add a single-lead ECG you take yourself, but the heart societies are clear that this is not enough to diagnose AFib. The next move is a medical-grade test, a 12-lead ECG or a patch monitor worn for one to two weeks, to confirm it. This is worth taking seriously because AFib raises stroke risk several-fold, and it is closely tied to heart failure and possibly dementia. If AFib is confirmed, the treatment plan is built around a stroke-risk score and a physician, and any decision about blood thinners belongs there, never with a watch. The encouraging part is that AFib is frequently improvable: losing weight, cutting or stopping alcohol, treating sleep apnea, and controlling blood pressure can meaningfully lower how often it occurs. So the right response to the notification is neither panic nor dismissal, but a proper workup.

Your watch flagged an irregular rhythm. What does that mean?

It means the device noticed your pulse behaving irregularly in a pattern that can signal atrial fibrillation, a common heart-rhythm disorder in which the upper chambers of the heart quiver instead of beating in an organized way. That is useful to know. But it is important to understand what the watch did and did not do.

Most wrist wearables screen for irregular rhythm using an optical sensor on the back of the watch, a technique called photoplethysmography, which measures the tiny changes in blood flow at your wrist to track your pulse. When the pulse looks irregular enough, often enough, the device sends an alert. Some devices, including the Apple Watch and several others, add a second feature: a single-lead ECG that you take by holding a finger to the crown, which records a brief electrical tracing and is more specific than the pulse sensor alone.

Neither of these is a diagnosis. The major heart-rhythm guidelines, including the 2024 European guideline, state plainly that this kind of wearable screening is not sufficient on its own to diagnose atrial fibrillation.¹ A diagnosis requires a medical-grade recording read by a clinician: a standard 12-lead ECG in a clinic, or, because AFib often comes and goes, a wearable patch monitor worn for one to two weeks (or a shorter Holter monitor) to catch an episode. So the correct reading of the notification is that your watch has done its job as a screen, and now a clinician needs to confirm the finding. Do not diagnose yourself, and above all, do not start or stop any medication based on the watch.

How accurate are these wearables?

Accurate enough to be useful as a screen, and not so accurate that a flag equals a diagnosis. Two large studies define the picture.

In the Apple Heart Study, which enrolled over 400,000 people, about 0.5% received an irregular-pulse notification.² Among the people who got a notification and then wore an ECG patch to check, about a third had atrial fibrillation confirmed on the patch. That number is easy to misread, so it is worth stating carefully: it does not mean a third of alerts are false and the rest true. AFib comes and goes, and a patch worn weeks after the alert can miss it, which pushes that figure down, while the study skewed young. The positive predictive value of the irregular-pulse notification, meaning how often a notification marked true AFib when checked against a recording at the same moment, was high, about 0.84. The Fitbit Heart Study, of similar size, found an even higher agreement when alerts were checked against a simultaneous patch.³

The flip side holds too. The optical pulse sensor can be fooled by motion and by ordinary extra beats, the premature beats that most hearts throw occasionally, which can look irregular without being AFib. And because it only flags what it happens to catch, it can miss AFib that comes in short bursts between readings. These devices are cleared by regulators as screening tools for people aged 22 and older who do not already have an AFib diagnosis, rather than as diagnostic instruments. The honest summary is that the technology is very good at raising a flag worth checking, and clearly not a substitute for a medical test.

Why does AFib matter?

Because it is one of the more consequential rhythm problems, and silently so, since many people feel little or nothing when they are in it.

The biggest concern is stroke. In AFib, blood can pool and clot in the quivering upper chamber of the heart, and a clot that travels to the brain causes a stroke. Untreated AFib raises stroke risk substantially, on the order of four to five times, and AFib-related strokes tend to be more severe than average. This is the main reason a flagged rhythm is worth confirming rather than ignoring. AFib is also tightly linked with heart failure, each one able to drive the other, and it is associated with a higher risk of cognitive decline and dementia, though that link is an association rather than proven cause and effect.

None of this is meant to alarm, because AFib is very manageable once it is known. The danger lies mostly in the AFib nobody has identified, which is the gap these wearables can help close. The point of confirming the diagnosis is to move a hidden risk into the open where it can be handled.

What happens after you see a doctor?

Confirming AFib turns a notification into a plan, and the plan has a few standard parts.

The first is confirmation itself, with a 12-lead ECG or a patch monitor, as above. Once AFib is documented, the most important early question is stroke prevention. Doctors estimate your personal stroke risk using a score called CHA2DS2-VASc, which adds up factors like age, high blood pressure, diabetes, prior stroke, and heart or vascular disease.⁴ If that risk is high enough, a blood thinner, called an anticoagulant, is recommended to prevent clots. The preferred drugs for most people are the newer direct oral anticoagulants, such as apixaban or rivaroxaban, which are generally chosen over warfarin, with the main exception being people who have a mechanical heart valve or significant mitral valve narrowing, who still need warfarin. This decision is made by a physician weighing stroke risk against bleeding risk, and it is the clearest example of why a watch cannot drive treatment.

The second part is managing the rhythm and rate itself. Some people are treated with rate control, medications that keep the heart from beating too fast while it is in AFib; others are treated with rhythm control, which aims to restore and hold a normal rhythm using medications or a procedure. Evidence has grown for stepping in earlier rather than waiting: a large trial found that starting rhythm control early, soon after diagnosis, improved outcomes compared with the older wait-and-see approach.⁵ One rhythm-control option is catheter ablation, a procedure that scars the small areas of heart tissue triggering the AFib, and for selected younger people with intermittent AFib it is now used as an early choice. Which path fits depends on symptoms, age, how long AFib has been present, and personal preference, decided with a cardiologist.

Can AFib be improved with lifestyle?

This is the part worth getting excited about, because AFib is not purely a matter of pills and procedures. A large share of it is driven by modifiable factors, and addressing them can meaningfully reduce how often AFib happens.

Weight is one of the strongest levers. In a study of people with AFib and excess weight, those who lost at least 10% of their body weight and kept it off were several times more likely to be free of AFib than those who did not.⁶ Alcohol is another: in a randomized trial, regular drinkers with AFib who cut alcohol out substantially lowered how often their AFib returned and how much of the time they spent in it.⁷ Sleep apnea matters too; it is common in people with AFib and often silent, and screening for and treating it is recommended and linked with fewer AFib episodes, even though the trial evidence on treatment is still mixed. Blood pressure control, and moderating other stimulants, round out the list.

One nuance surprises people: exercise has a U-shape here. Moderate, regular activity lowers AFib risk, but many years of high-volume endurance training, the marathon-and-beyond kind, can raise it. For most people the message is simply to stay active; for the lifelong heavy-endurance athlete, AFib is one reason the very high end has diminishing returns. Taken together, the lifestyle side means a diagnosis is often the start of getting better rather than merely a label.

Guidance from the Clinic

"I see this weekly now: someone comes in shaken because their watch said atrial fibrillation. The first thing I do is take it seriously and slow it down. The watch is a good screen, and I would rather know than not, but it is not a diagnosis, so we confirm it properly with an ECG or a patch monitor before we call it anything. If it is confirmed, the two questions I care about most are the stroke risk, which decides whether a blood thinner is warranted, and the drivers behind it, because so much AFib is tied to weight, alcohol, sleep apnea, and blood pressure. That second part is where patients have the most power. What I never want is someone starting or stopping a medication because of a phone alert, or the opposite, ignoring a true warning because they decided the watch was wrong. The right path is the unglamorous one: confirm it, then treat it well."

Key Takeaways

A smartwatch irregular-rhythm or AFib alert is a screening flag rather than a diagnosis; the heart societies agree wearable screening alone cannot diagnose atrial fibrillation.
Confirm it with a medical-grade test, a 12-lead ECG or a patch monitor worn for one to two weeks, because AFib often comes and goes.
The wearables are a useful screen, with high accuracy when their signal matches a simultaneous recording, but they produce false alarms from motion and extra beats and can miss short episodes.
AFib matters mainly because it raises stroke risk several-fold; whether to use a blood thinner is decided by a stroke-risk score and a physician, never by a watch.
AFib is often improvable: losing at least 10% of body weight, cutting out alcohol, treating sleep apnea, and controlling blood pressure all reduce how often it happens.

Stroke Prevention - why AFib matters and how stroke risk is lowered
HRV and Resting Heart Rate - the other heart signals your wearable tracks
At-Home Monitoring - using home devices well, without over-reading them
Alcohol and Longevity - the drinking-and-heart connection in depth
Sleep Apnea and Testosterone - the silent driver behind much AFib and metabolic trouble
Sleep Apnea: Wearables and Home Testing - another thing your watch may flag, and a common driver of AFib

Scientific References

Van Gelder IC, Rienstra M, Bunting KV, et al. "2024 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with the EACTS." European Heart Journal. 2024;45(36):3314-3414.
Perez MV, Mahaffey KW, Hedlin H, et al. "Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation." New England Journal of Medicine. 2019;381(20):1909-1917.
Lubitz SA, Faranesh AZ, Selvaggi C, et al. "Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study." Circulation. 2022;146(19):1415-1424.
Joglar JA, Chung MK, Armbruster AL, et al. "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation." Circulation. 2024;149(1):e1-e156.
Kirchhof P, Camm AJ, Goette A, et al. "Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4)." New England Journal of Medicine. 2020;383(14):1305-1316.
Pathak RK, Middeldorp ME, Meredith M, et al. "Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort (LEGACY)." Journal of the American College of Cardiology. 2015;65(20):2159-2169.
Voskoboinik A, Kalman JM, De Silva A, et al. "Alcohol Abstinence in Drinkers with Atrial Fibrillation." New England Journal of Medicine. 2020;382(1):20-28.

Fishtown Medicine | Cardiovascular risk

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Start your intake

Frequently Asked Questions

Common Questions

Not necessarily, and not confirmed. A watch alert is a screening flag rather than a diagnosis. The device reads your pulse optically, and its single-lead ECG helps, but the heart societies agree neither is enough to diagnose atrial fibrillation on its own. You need a medical-grade test, a 12-lead ECG or a patch monitor worn for one to two weeks, to confirm it. Take the alert seriously and get it checked, but do not conclude you have AFib, and do not start or stop any medication based on the watch.

Good as a screen, not perfect. In the Apple Heart Study, about a third of people who got an alert and then wore an ECG patch had AFib confirmed, and when the watch signal lined up with a simultaneous recording its accuracy was high. The Fitbit study found similarly high agreement. But these sensors produce false alarms from motion and ordinary extra heartbeats, and can miss AFib that comes in short bursts. They are cleared as screening tools, not diagnostic devices, which is why confirmation matters.

See a clinician and get a proper recording. That usually means a 12-lead ECG in the office and, because AFib often comes and goes, a wearable patch monitor worn for one to two weeks (or a shorter Holter monitor) to try to capture an episode. Bring the watch data, including any single-lead ECG tracings you saved, since they help. Do not diagnose yourself and do not change any medication on your own. The goal of the visit is to confirm whether AFib is truly present and, if so, to assess your stroke risk.

No. Whether a blood thinner is recommended depends on your personal stroke risk, estimated with a score called CHA2DS2-VASc that weighs factors like age, blood pressure, diabetes, and prior stroke. People at higher risk benefit from anticoagulation to prevent stroke; people at very low risk often do not need it. The newer direct oral anticoagulants are generally preferred over warfarin for most people. This is a physician's decision balancing stroke prevention against bleeding risk, and it is never made from a watch reading.

It can often be reduced, and sometimes people go long stretches without episodes, though it is better described as manageable and improvable than cured. The strongest levers are weight loss, cutting out alcohol, treating sleep apnea, and controlling blood pressure, each of which has been shown to lower how often AFib occurs. Procedures like catheter ablation can also reduce or eliminate episodes for many people. So a diagnosis is frequently the beginning of getting better, particularly when the drivers behind it are addressed.

Deep-Dive Questions

Because of what the sensor measures and how AFib behaves. The wrist sensor reads your pulse optically, which is an indirect signal, good for noticing that the rhythm is irregular but not detailed enough to prove the specific electrical pattern that defines atrial fibrillation. The single-lead ECG on some watches is closer, but it is one view of the heart's electrical activity, where a diagnostic 12-lead ECG records twelve, and a cardiologist reads the tracing to distinguish AFib from other irregular rhythms and from artifact. On top of that, AFib is often paroxysmal, meaning it comes and goes, so a single moment of recording, whether from a watch or a brief office ECG, can miss it altogether, which is why a monitor worn over one to two weeks is often needed. The watch is built to raise a well-timed flag across everyday life, a clear strength, but confirming and characterizing the rhythm is a different job.

No, and the number that worries people is usually misunderstood. The often-quoted figure, that about a third of alerted people who wore a follow-up patch had AFib, undercounts the truth for a specific reason: the patch was worn weeks after the alert, and because AFib comes and goes, the patch frequently missed episodes that were truly there at the time of the alert. When researchers instead compared the watch's signal against a recording happening at the same moment, the agreement was high. So the technology is better than the headline number suggests. The honest framing is that these devices are a useful screen that surfaces true AFib in people who did not know they had it, while still producing enough false alarms that every flag needs medical confirmation before it means anything.

Because atrial fibrillation is, for many people, partly a disease of the atria being stressed and remodeled by chronic strain, and those strains are often modifiable. Excess weight raises the heart's workload, promotes inflammation, and is tied to sleep apnea and high blood pressure, all of which stretch and irritate the upper chambers where AFib originates; losing a meaningful amount of weight relieves several of those pressures at once, which is why weight loss has been shown to lower AFib burden so effectively. Alcohol has more direct effects on the heart's electrical properties and on the atria, and it is a common trigger, so removing it reduces episodes in regular drinkers. The broader lesson is that the atria can partly recover when the forces distorting them ease, which is why lifestyle change is not a soft add-on here but one of the more powerful tools.

Once confirmed, yes, it is the same condition, and that is the point of confirming it. The value of the wearables is that they catch AFib in people who feel nothing and would otherwise not know, and silent AFib carries the same stroke risk as symptomatic AFib. That said, not every irregular-rhythm alert turns out to be AFib; some are false alarms or other, more benign irregularities, which is why the confirming test matters before anyone attaches the diagnosis or its consequences. So the accurate way to hold it is that a watch alert is a possible early warning of the same serious condition a doctor treats, worth neither dismissing as a gadget quirk nor accepting as fact until a proper recording settles it.

Ready when you are